News

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Is Ozempic fueling a new era of body image pressure? Join The Independent Debate - THE INDEPENDENT DEBATE: As weight-loss ...
After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the ...
Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic and Wegovy ... “Now that it’s coming off shortage, I am ...
(HealthDay News) — A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. That means ...